Award recordCONTRACT

BAYER HEALTHCARE PHARMACEUTICALS INC

PIID 36C26019F0033· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $180,662 net obligations· UEI V1EVGCK7XES8· NJ

Description

XOFIGO RA 223 INJECTIONS

First action · last action
2018-10-29 · 2020-07-29
Transactions
2
First transaction's obligation
$356,085
Base + all options value (sum of deltas)
$180,662
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2202D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$356,085$0Base award · 2018-10-29 · this action $356,085 · running total $356,085Modification P00001 · 2020-07-29 · this action -$175,423 · running total $180,662
  • Base2018-10-29+$356,085= $356,085
  • Mod P000012020-07-29-$175,423= $180,662
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-10-29+$356,085$356,085XOFIGO RA 223 INJECTIONS
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-07-29−$175,423$180,662XOFIGO RA 223 INJECTIONS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI V1EVGCK7XES8)

AwardOffice · PSC / listingNet obligationsFY
36C25626N0492256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS$386,860FY2026
36C26226F0163262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$181,386FY2026
36C26026F0086260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$80,663FY2026
36C26126N0199261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$101,567FY2026
36C25626N0126256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS$214,783FY2026
36E79725A0028NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26019F0033_3600_V797P2202D_3600 · retrieved 2026-09-26.